Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by Abruzzoon Aug 09, 2017 9:28pm
145 Views
Post# 26564058

BRIEF-Valeant says subsidiaries in Australia are under audit

BRIEF-Valeant says subsidiaries in Australia are under auditAug 9 (Reuters) - Valeant - * Says subsidiaries in australia are under audit by the australian tax office for various years beginning in 2010 * Says the australian tax office issued a notice of assessment for tax years 2011 through 2017 in the aggregate amount of $117 million. * Says company disagrees with the australian tax office's assessment and continues to believe that its tax positions are appropriate Source text: (bit.ly/2hHFMNM) Further company coverage
<< Previous
Bullboard Posts
Next >>